Tanglao, B-jay .

HRN: 21-88-51  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/09/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
09/09/2022
09/16/2022
IV
470mg
Q6hours
Cellulitis
Waiting Final Action 
09/09/2022
MUPIROCIN 2%, 15G (TUBE)
09/09/2022
09/16/2022
TOPICAL
As Needed
TID
Cellulitis
Waiting Final Action 
09/09/2022
OXACILLIN 500MG (VIAL)
09/09/2022
09/16/2022
IV
315mg
Q6hours
Cellulitis
Waiting Final Action 
01/26/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
01/26/2023
02/02/2023
IV
575mg
Q8
Pcap C
Waiting Final Action 
01/28/2023
CEFTRIAXONE 1G (VIAL)
01/28/2023
02/04/2023
IV
1 G
Q12
PCAP C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: